Alyeska Investment Group
TNGX icon

Alyeska Investment Group’s Tango Therapeutics TNGX Stock Holding History

Alyeska Investment Group’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$360K Buy
+17,198
New +$239K ﹤0.01% 594
2023
Q3 		– Sell
-74,338
Closed -$247K – 624
2023
Q2 		$247K Hold
74,338
– – ﹤0.01% 521
2023
Q1 		$294K Hold
74,338
– – ﹤0.01% 429
2022
Q4 		$539K Hold
74,338
– – 0.01% 370
2022
Q3 		$269K Hold
74,338
– – ﹤0.01% 373
2022
Q2 		$337K Hold
74,338
– – ﹤0.01% 539
2022
Q1 		$563K Sell
74,338
-50,000
-40% -$433K 0.01% 541
2021
Q4 		$1.36M Sell
124,338
-300,300
-71% -$3.61M 0.02% 491
2021
Q3 		$5.49M Sell
424,638
-9,455
-2% -$113K 0.07% 305
2021
Q2 		$4.94M Sell
434,093
-8,219
-2% -$92.3K 0.06% 352
2021
Q1 		$4.92M Sell
442,312
-57,688
-12% -$663K 0.06% 332
2020
Q4 		$5.72M Sell
500,000
-4,000
-0.8% -$42.1K 0.08% 252
2020
Q3 		$5.22M Buy
+504,000
New +$5.15M 0.08% 257

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Alyeska Investment Group's TNGX Position: Q1 2026 in Review

Alyeska Investment Group opened a new position in Tango Therapeutics (TNGX) in Q1 2026: 17,198 shares worth $360K. The stake represents ﹤0.01% of the portfolio and ranks #594 among its holdings. This is a return to the name: Alyeska Investment Group previously reported a position in TNGX as recently as Q2 2023.

Alyeska Investment Group first reported a position in TNGX in Q3 2020 and has held it in 13 quarters since. The position peaked at $5.72M in Q4 2020. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Alyeska Investment Group held 17,198 shares of Tango Therapeutics worth $360K as of Q1 2026.
  • Tango Therapeutics was a new Alyeska Investment Group position in Q1 2026.
  • Tango Therapeutics made up ﹤0.01% of Alyeska Investment Group's portfolio in Q1 2026, its #594 holding.
  • Alyeska Investment Group first reported a position in Tango Therapeutics in Q3 2020 and has held it in 13 quarters since.
  • Alyeska Investment Group's Tango Therapeutics position peaked at $5.72M in Q4 2020.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.